| Literature DB >> 24143071 |
Marjorie J Rah1, Jeffery Schafer, Lening Zhang, Osbert Chan, Lipika Roy, Joseph T Barr.
Abstract
BACKGROUND: Concerns regarding the safety of cosmetically tinted contact lenses have been reported in the literature. The purpose of this paper is to evaluate the safety of cosmetically tinted contact lenses in a large number of patients across six clinical trials that varied from 1 week to 3 months in duration.Entities:
Keywords: compliance; contact lens; cosmetically tinted contact lens; hydrogel
Year: 2013 PMID: 24143071 PMCID: PMC3798236 DOI: 10.2147/OPTH.S51600
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Cosmetically tinted lens use among all contact lens wearers.
Profile of study design for the six studies included in the meta-analysis
| Study | Design | Study duration | Visits | Sites (n) | Study dates | Lens designs tested |
|---|---|---|---|---|---|---|
| A | Parallel, bilateral, randomized, open-label | One month | Baseline, 2 weeks, one month | 10 sites (one Hong Kong, 2 Taiwan, 7 United States) | April to August 2010 | Naturelle Limbal ring daily disposable (Bausch + Lomb) and 1-Day Acuvue Define Accent |
| B | Bilateral, single arm, open-label | One month | Baseline, 2 weeks, one month | 6 sites (4 Singapore and 2 Hong Kong) | February to June 2010 | Lacelle Limbal ring planned replacement at two weeks (Bausch + Lomb) |
| C | Bilateral, single arm, open-label | One week | Baseline, one week | 7 sites (5 Hong Kong, 2 Singapore) | August to November 2010 | Naturelle Limbal ring daily disposable (Bausch + Lomb) |
| D | Bilateral, single arm, open-label | Three months | Baseline, one month, 3 months | 6 sites (3 Hong Kong, 3 Singapore) | August to December 2011 | Alamode Traditional/annual cosmetic tinted lens (Bausch + Lomb) |
| E | Bilateral, single arm, open-label | One month | Baseline, one month | 6 sites (3 Hong Kong, 2 Malaysia, 1 Singapore) | November to December 2011 | Lacelle Colored – cosmetic Daily disposable. (Bausch + Lomb) |
| F | Bilateral, single arm, open-label | One week | Baseline, one week | 7 sites (6 Hong Kong and 1 Singapore) | September to October 2011 | Lacelle Limbal ring daily disposable (Bausch + Lomb) |
Notes:
For study A, only data for Naturelle lenses are represented in the meta-analysis. Bausch + Lomb is used for Bausch & Lomb Incorporated.
Accountability of subjects for each study
| Study A | Study B | Study C | Study D | Study E | Study F | Total n (%) | |
|---|---|---|---|---|---|---|---|
| Total enrolled | 100 | 140 | 218 | 145 | 140 | 140 | 883 |
| Eligible | 95 | 139 | 212 | 145 | 140 | 140 | 871 (98.6%) |
| Completed | 85 | 135 | 209 | 143 | 139 | 140 | 851 (96.4%) |
| Discontinued | 10 | 4 | 3 | 2 | 1 | 0 | 20 (2.3%) |
| Ineligible at baseline | 5 | 1 | 6 | 0 | 0 | 0 | 12 (1.4%) |
| Completed | 2 | 1 | 2 | 0 | 0 | 0 | 5 (0.6%) |
| Discontinued | 3 | 0 | 4 | 0 | 0 | 0 | 7 (0.8%) |
Patient demographics summarized across all studies
| Age (years) (mean ± SD) | 26.8 ± 6.6 |
| Sex | |
| % female | 86.7 |
| % male | 13.3 |
| Race | |
| % Asian | 100 |
| Baseline sphere, D (mean ± SD) | −3.30 ± 1.7 |
| Baseline cylinder, D (mean ± SD) | −0.40 ± 0.4 |
| Iris color | |
| % brown | 96.4 |
| % hazel | 1.6 |
| % other | 2.0 |
| Prestudy average daily lens wear time, hours (mean ± SD) | 10.4 ± 2.6 |
Abbreviations: SD, standard deviation; D, diopters.
Number and percentage of all eligible dispensed eyes with each slit-lamp grade for follow-up visit 1 (all studies) and follow-up visit 2 (applicable only for studies A, B, and D)
| Epithelial edema n(%) | Epithelial microcysts n(%) | Corneal staining n(%) | Bulbar injection n(%) | Limbal injection n(%) | Upper lid tarsal abnormality n(%) | Corneal neovascularization n(%) | Corneal infiltrates n(%) | |
|---|---|---|---|---|---|---|---|---|
| Follow-up visit 1 | ||||||||
| Grade 0 | 1,729(99.9%) | 1,730(100%) | 1,089(62.9%) | 1,340(77.5%) | 1,330(76.9%) | 1,122(64.9%) | 1,601 (92.5%) | 1,727(99.8%) |
| Grade 1 | 1 (0.1%) | 0 (0.0%) | 586 (33.9%) | 387 (22.4%) | 388 (22.4%) | 606 (35.0%) | 129 (7.5%) | 3 (0.2%) |
| Grade 2 | 0 (0.0%) | 0 (0.0%) | 54(3.1%) | 3 (0.2%) | 12 (0.7%) | 2(0.1%) | 0 (0.0%) | 0 (0.0%) |
| Grade 3 | 0 (0.0%) | 0 (0.0%) | 1 (0.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Grade 4 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Follow-up visit 2 | ||||||||
| Grade 0 | 726(100%) | 726(100%) | 341 (47.0%) | 558 (76.9%) | 496 (68.3%) | 477 (65.7%) | 664 (91.5%) | 725 (99.9%) |
| Grade 1 | 0 (0.0%) | 0 (0.0%) | 310(42.7%) | 166(22.9%) | 224 (30.9%) | 245 (33.7%) | 62 (8.5%) | 1 (0.1%) |
| Grade 2 | 0 (0.0%) | 0 (0.0%) | 71 (9.8%) | 2 (0.3%) | 6 (0.8%) | 4 (0.6%) | 0 (0.0%) | 0 (0.0%) |
| Grade 3 | 0 (0.0%) | 0 (0.0%) | 4 (0.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Grade 4 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |